Ngwaga Tshegofatso, Chauhan Deepika, Shames Stephanie R
Division of Biology, Kansas State University, Manhattan, KS, United States.
Front Cell Infect Microbiol. 2021 Feb 3;10:593823. doi: 10.3389/fcimb.2020.593823. eCollection 2020.
Many Gram-negative bacterial pathogens employ translocated virulence factors, termed effector proteins, to facilitate their parasitism of host cells and evade host anti-microbial defenses. However, eukaryotes have evolved to detect effector-mediated virulence strategies through a phenomenon termed effector-triggered immunity (ETI). Although ETI was discovered in plants, a growing body of literature demonstrates that metazoans also utilize effector-mediated immunity to detect and clear bacterial pathogens. This mini review is focused on mechanisms of effector-mediated immune responses by the accidental human pathogen . We highlight recent advancements in the field and discuss the future prospects of harnessing effectors for the development of novel therapeutics, a critical need due to the prevalence and rapid spread of antibiotic resistance.
许多革兰氏阴性细菌病原体利用被称为效应蛋白的易位毒力因子来促进其对宿主细胞的寄生,并逃避宿主的抗菌防御。然而,真核生物已经进化出通过一种称为效应子触发免疫(ETI)的现象来检测效应子介导的毒力策略。尽管ETI是在植物中发现的,但越来越多的文献表明,后生动物也利用效应子介导的免疫来检测和清除细菌病原体。这篇小型综述聚焦于偶然感染人类的病原体的效应子介导的免疫反应机制。我们强调了该领域的最新进展,并讨论了利用效应子开发新型疗法的未来前景,鉴于抗生素耐药性的普遍存在和迅速传播,这是一项迫切需求。